Thought cannabis was the most controversial treatment? Think again.
Works Cited
Johnson, M.W., Griffiths, R.R. Potential Therapeutic Effects of Psilocybin. Neurotherapeutics 14, 734–740 (2017). [ Ссылка ]
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. [ Ссылка ]
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., . . . Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627. doi:10.1016/s2215-0366(16)30065-7
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983-992. doi:10.1177/0269881114548296
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., . . . Nutt, D. J. (2017). Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Scientific Reports, 7(1). doi:10.1038/s41598-017-13282-7
Han, W., Dang, R., Xu, P., Li, G., Zhou, X., Chen, L., . . . Jiang, P. (2019). Altered fibrinolytic system in rat models of depression and patients with first-episode depression. Neurobiology of Stress, 11, 100188. doi:10.1016/j.ynstr.2019.100188
Bauer, B. (2020, May 19). The Pharmacology of Psilocybin and Psilocin. Retrieved July 23, 2020, from [ Ссылка ]
